105 related articles for article (PubMed ID: 736583)
1. Fate of pemphigus antibody following successful therapy. Preliminary evaluation of pemphigus antibody determinations to regulate therapy.
O'Loughlin S; Goldman GC; Provost TT
Arch Dermatol; 1978 Dec; 114(12):1769-72. PubMed ID: 736583
[TBL] [Abstract][Full Text] [Related]
2. Adjuvant therapy of pemphigus.
Bystryn JC
Arch Dermatol; 1984 Jul; 120(7):941-51. PubMed ID: 6375579
[TBL] [Abstract][Full Text] [Related]
3. Immunopathological examination of esophagus as a useful criterion of cure in pemphigus vulgaris.
Torzecka JD; Sysa-Jedrzejowska A; Waszczykowska E; Wozniacka A; Dziankowska-Bartkowiak B; Narbutt J
J Eur Acad Dermatol Venereol; 1999 Mar; 12(2):115-8. PubMed ID: 10343938
[TBL] [Abstract][Full Text] [Related]
4. Value of direct immunofluorescence in predicting remission in pemphigus vulgaris.
Balighi K; Taheri A; Mansoori P; Chams C
Int J Dermatol; 2006 Nov; 45(11):1308-11. PubMed ID: 17076711
[TBL] [Abstract][Full Text] [Related]
5. Management of pemphigus in pediatric patients.
Gürcan H; Mabrouk D; Razzaque Ahmed A
Minerva Pediatr; 2011 Aug; 63(4):279-91. PubMed ID: 21909064
[TBL] [Abstract][Full Text] [Related]
6. Therapy of refractory pemphigus vulgaris with monoclonal anti-CD20 antibody (rituximab).
Morrison LH
J Am Acad Dermatol; 2004 Nov; 51(5):817-9. PubMed ID: 15523367
[TBL] [Abstract][Full Text] [Related]
7. Cyclosporine therapy should be considered for maintenance of remission in patients with pemphigus.
Vardy DA; Cohen AD
Arch Dermatol; 2001 Apr; 137(4):505-6. PubMed ID: 11295940
[No Abstract] [Full Text] [Related]
8. Intravenous immunoglobulin therapy in the treatment of patients with pemphigus vulgaris unresponsive to conventional immunosuppressive treatment.
Ahmed AR
J Am Acad Dermatol; 2001 Nov; 45(5):679-90. PubMed ID: 11606916
[TBL] [Abstract][Full Text] [Related]
9. Prolonged remission after immunosuppressive therapy in six dogs with pemphigus foliaceus.
Olivry T; Bergvall KE; Atlee BA
Vet Dermatol; 2004 Aug; 15(4):245-52. PubMed ID: 15305932
[TBL] [Abstract][Full Text] [Related]
10. Improved protocol for treatment of pemphigus vulgaris with protein A immunoadsorption.
Shimanovich I; Herzog S; Schmidt E; Opitz A; Klinker E; Bröcker EB; Goebeler M; Zillikens D
Clin Exp Dermatol; 2006 Nov; 31(6):768-74. PubMed ID: 16824051
[TBL] [Abstract][Full Text] [Related]
11. Anti-CD20 monoclonal antibody (rituximab) in the treatment of pemphigus.
Arin MJ; Engert A; Krieg T; Hunzelmann N
Br J Dermatol; 2005 Sep; 153(3):620-5. PubMed ID: 16120153
[TBL] [Abstract][Full Text] [Related]
12. Steroid sparing effect of intravenous immunoglobulin therapy in patients with pemphigus foliaceus.
Sami N; Qureshi A; Ahmed AR
Eur J Dermatol; 2002; 12(2):174-8. PubMed ID: 11872417
[TBL] [Abstract][Full Text] [Related]
13. Mucous membrane manifestations of pemphigus vulgaris. A 25-year survey of 185 patients treated with corticosteroids or with combination of corticosteroids with methotrexate or heparin.
Mashkilleyson N; Mashkilleyson AL
Acta Derm Venereol; 1988; 68(5):413-21. PubMed ID: 2461025
[TBL] [Abstract][Full Text] [Related]
14. Effect of plasmapheresis therapy on circulating levels of pemphigus antibodies.
Tan-Lim R; Bystryn JC
J Am Acad Dermatol; 1990 Jan; 22(1):35-40. PubMed ID: 2298963
[TBL] [Abstract][Full Text] [Related]
15. ELISA testing of anti-desmoglein 1 and 3 antibodies in the management of pemphigus.
Abasq C; Mouquet H; Gilbert D; Tron F; Grassi V; Musette P; Joly P
Arch Dermatol; 2009 May; 145(5):529-35. PubMed ID: 19451496
[TBL] [Abstract][Full Text] [Related]
16. Treatment of refractory pemphigus vulgaris with rituximab (anti-CD20 monoclonal antibody).
Dupuy A; Viguier M; Bédane C; Cordoliani F; Blaise S; Aucouturier F; Bonnetblanc JM; Morel P; Dubertret L; Bachelez H
Arch Dermatol; 2004 Jan; 140(1):91-6. PubMed ID: 14732665
[TBL] [Abstract][Full Text] [Related]
17. Treatment of severe pemphigus with rituximab: report of 12 cases and a review of the literature.
Cianchini G; Corona R; Frezzolini A; Ruffelli M; Didona B; Puddu P
Arch Dermatol; 2007 Aug; 143(8):1033-8. PubMed ID: 17709662
[TBL] [Abstract][Full Text] [Related]
18. [Therapy of pemphigus. Critical remarks based on 44 clinical cases].
Smolle J
Hautarzt; 1985 Feb; 36(2):96-102. PubMed ID: 2985524
[TBL] [Abstract][Full Text] [Related]
19. Twelve-year clinico-therapeutic experience in pemphigus: a retrospective study of 54 cases.
Mahajan VK; Sharma NL; Sharma RC; Garg G
Int J Dermatol; 2005 Oct; 44(10):821-7. PubMed ID: 16207182
[TBL] [Abstract][Full Text] [Related]
20. [Immunodepressants in the overall therapy of pemphigus].
Kalamkarian AA; Trofimova LIa; Khapilova VI
Vestn Dermatol Venerol; 1979 Dec; (12):28-32. PubMed ID: 525019
[No Abstract] [Full Text] [Related]
[Next] [New Search]
